As a Free StocksGuide user, you can view scores for all 7,031 stocks worldwide.
29 Analysts have issued a IQVIA forecast:
29 Analysts have issued a IQVIA forecast:
| Sep '25 |
+/-
%
|
||
| Revenue | 15,904 15,904 |
4%
4%
|
|
| Gross Profit | 5,372 5,372 |
0%
0%
|
|
| EBITDA | 3,388 3,388 |
3%
3%
|
|
| EBIT (Operating Income) EBIT | 2,258 2,258 |
4%
4%
|
|
| Net Profit | 1,283 1,283 |
9%
9%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Provides biopharmaceutical development services and commercial outsourcing services
| Head office | United States |
| CEO | Ari Bousbib |
| Employees | 88,000 |
| Founded | 1950 |
| Website | ir.iqvia.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


